Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |
mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |